Thus, activating caspase-3/GSDME-dependent pyroptosis specifically in CXCR4+ HNSCC tumor cells may represent a novel and enticing approach for the treatment of HNSCC patients. Here, CXCR4 is linked to head and neck squamous cell carcinoma.